#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute graft versus host disease in liver Salivary gland cancer Alexander disease Acute myeloid leukaemia recurrent Gastrointestinal stromal tumour Lymphangiosarcoma Neurofibroma Laryngeal squamous cell carcinoma Neurofibromatosis Dupuytren's contracture Chordoma Arterial tortuosity syndrome Brain injury Diffuse large B-cell lymphoma refractory Hypoxic-ischaemic encephalopathy More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Factor VIII deficiency – Diagnostics Metachromatic leukodystrophy – Basic Information Arterial tortuosity syndrome – Basic Information Netherton’s syndrome Pleural mesothelioma malignant – Life with Disease Gaucher’s disease type I – Diagnostics Short-bowel syndrome – Diagnostics Mucopolysaccharidosis I – Basic Information Ehlers-Danlos syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VANADIUM OXIDE SULFATE Cisatracurium Besilate Tranexamic Acid Bromocriptine 4-IODOPHENYLALANINE I-131 VERCIRNON Aluminium Casimersen Reparixin Meropenem Trihydrate Haloperidol Epirubicin Zofenopril Calcium Mbf-118 Holcus Lanatus Pollen Extract Lenomorelin Ads-010 SECRETIN SYNTHETIC HUMAN Camizestrant Azd2693 Sodium More therapies…

    Learn about Your Condition

    Herpes simplex Fontan procedure Electronic cigarette user Cerebral palsy Breast cancer male Limb reduction defect Injection site pain Androgenetic alopecia Metastases to lymph nodes Mitral valve prolapse Skin ulcer Mitral valve incompetence Myocarditis post infection Neonatal respiratory failure Hernia repair More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Timing of Chemotherapy with Paclitaxel Albumin-Bound and Drug Combination for Patients with Metastatic Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Gemcitabine
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Ertapenem
    • Pivmecillinam Hydrochloride
    • Amoxicillin
    Sweden

  • Study on Rectal Cancer Treatment with Radiotherapy, Atezolizumab, and Bevacizumab for Patients with Low- to Intermediate-Risk

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    The Netherlands

  • Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Art0380 Mesilate
    • Irinotecan Hydrochloride
    • Gemcitabine Hydrochloride
    France Spain

  • Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • Precursor T-lymphoblastic lymphoma/leukaemia refractory
    • Precursor B-lymphoblastic lymphoma recurrent
    Investigated Drugs:
    • Dasatinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

  • Study on the Use of Sulfur Hexafluoride in Ultrasound for Diagnosing Adnexal Torsion in Patients with Suspected Ovarian Twisting

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Sulfur Hexafluoride
    France
Previous Page
1 … 631 632 633 634 635 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!